Nebenwirkungen · Roclanda
Roclanda 50 micrograms/ml + 200 micrograms/ml eye drops, solution · Abschnitt 4.8 · PDF-Seite 7
HOS-144346 · Präparat HOS-099162
Conjunctival hyperaemia Conjunctival hyperaemia was the most frequently reported adverse reaction associated with latanoprost + netarsudil treatment in clinical studies and it is attributed to the vasodilation effect of the Rho kinase inhibitor medicinal product class. Conjunctival hyperaemia was typically mild in severity and sporadic. However, there was a relatively small proportion of subjects with moderate or severe hyperaemia who discontinued treatment because of this adverse reaction (5% in Phase 3 clinical studies).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-12T11:25:00Z · SHA-256 87849a8418cacd034df5be09c055fa9f8742a5f7b9c507d3191aa1e9899e02d9 · Passage 514c90fcf16ae1194f47fa2b09f84c6034f31d4f8e3aeaa0a86353cf18353249 · Zeichen 8599–9127 im Abschnitt